These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24484721)

  • 1. Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer.
    Janssen-Heijnen ML; Maas HA; Koning CC; van der Bruggen-Bogaarts BA; Groen HJ; Wymenga AN
    J Geriatr Oncol; 2014 Jan; 5(1):71-7. PubMed ID: 24484721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J; Chen P; Dai CH; Li XQ; Bao QL
    Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
    J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
    Janssen-Heijnen MLG; Maas HAAM; van de Schans SAM; Coebergh JWW; Groen HJM
    Ann Oncol; 2011 Apr; 22(4):821-826. PubMed ID: 20929965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients.
    Schild SE; Zhao L; Wampfler JA; Daniels TB; Sio T; Ross HJ; Paripati H; Marks RS; Yi J; Liu H; He Y; Yang P
    Clin Lung Cancer; 2019 Jul; 20(4):313-321. PubMed ID: 31155475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(high)CD57(+) T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer.
    Dobrovolskienė NT; Cicėnas S; Kazlauskaitė N; Mišeikytė-Kaubrienė E; Krasko JA; Ostapenko V; Pašukonienė V; Strioga MM
    Lung Cancer; 2015 Nov; 90(2):326-33. PubMed ID: 26319316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
    Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
    J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.
    Fiegl M; Pircher A; Waldthaler C; Gamerith G; Kocher F; Pall G; Nevinny M; Schmid T; Sterlacci W; Jamnig H; Zangerl G; Zabernigg A; Oberaigner W; Hilbe W
    Lung Cancer; 2014 May; 84(2):168-74. PubMed ID: 24646832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
    Davidoff AJ; Gardner JF; Seal B; Edelman MJ
    J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
    Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
    Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
    Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in study on the therapy for limited-stage small cell lung cancer].
    Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):857-62. PubMed ID: 23982001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Saijo N; Nishiwaki Y
    J Thorac Oncol; 2008 Jul; 3(7):723-7. PubMed ID: 18594317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older.
    Shimizu T; Sekine I; Sumi M; Ito Y; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2007 Mar; 37(3):181-5. PubMed ID: 17426103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.
    Mountzios G; Emmanouilidis C; Vardakis N; Kontopodis E; Hatzidaki D; Popis E; Karachaliou N; Kotsakis A; Agelidou M; Georgoulias V
    Lung Cancer; 2012 Jul; 77(1):146-50. PubMed ID: 22418242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
    Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
    Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-line chemotherapy in small-cell lung cancer: an international analysis.
    Simos D; Sajjady G; Sergi M; Liew MS; Califano R; Ho C; Leighl N; White S; Summers Y; Petrcich W; Wheatley-Price P
    Clin Lung Cancer; 2014 Mar; 15(2):110-8. PubMed ID: 24365050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.